Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734968 · ClinicalTrials.gov registry record · Phase 4
Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
A Phase 4 study of Stress Incontinence, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT00734968 is a Phase 4 study of Stress Incontinence that has completed, run by University of Missouri-Columbia. The registered enrollment target is 161 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00734968, a Phase 4 study of Stress Incontinence, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will determine whether post-operative prophylaxis with macrobid will decrease the incidence of postoperative urinary tract infection in women receiving sub-urethral slings for the treatment of urinary incontinence.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Nitrofurantoin
Study Locations (1)
Texas
- Scott and White Hosptial, Texas A&M University - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00734968
The ClinicalTrials.gov registry entry for NCT00734968 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00734968 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00734968 about?
NCT00734968 is a clinical study titled "Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence". This project will determine whether post-operative prophylaxis with macrobid will decrease the incidence of postoperative urinary tract infection in women receiving sub-urethral slings for the treatment of urinary incontinence.
What is the current status of trial NCT00734968?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 161 participants. The study started on 2008-05. Estimated completion is 2010-05.
What conditions does trial NCT00734968 study?
This clinical trial studies the following conditions: Stress Incontinence.
What interventions are being tested in trial NCT00734968?
The interventions under investigation include: Placebo (OTHER), Nitrofurantoin (DRUG).
Who is sponsoring clinical trial NCT00734968?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00734968 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.